ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 5, 1990

Novel Treatment Modalities Tested Against Bladder Cancer

May 27, 2005

Cooperative Group Chairmen, OPRR Seek Agreement On Assurances

January 6, 1984

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

Flood Asks ACCC for Greater Community Effort

February 14, 1975